A Lot to Chew On

Complex layers of science, policy, and public opinion surround the things we eat and drink.

Written byMary Beth Aberlin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ANDRZEJ KRAUZEIn his very funny 1973 sci-fi film Sleeper, Woody Allen plays a health-food store owner who is revived after 200 years of cryopreservation. His request for a breakfast of “wheat germ, organic honey, and tiger’s milk” bewilders the doctors who supervised his thawing: “Those are the charmed substances that some years ago were thought to contain life-preserving properties,” says one doctor, to which the other queries, “You mean there was no deep fat? No steak or cream pies or . . . hot fudge?” “Those were thought to be unhealthy—precisely the opposite of what we now know to be true,” explains the first medic.

Food provides organisms with the vital energy and nutrients they need to survive. But for humans, food is far more than simple sustenance. This issue of The Scientist peels back layers of complexity to report on the science that is revolutionizing nutrition and agriculture from the inside out. What we’ve uncovered is a cornucopia of technical progress in plant breeding spurred by advances in genomics and gene editing—advances that could feed many more people and counter climate-change threats to food crops.

In “Putting Up Resistance,” associate editor Kerry Grens documents crop scientists’ growing worries that a fungal attack on wheat plants could spread around the world, decimating a crop with insufficient defense mechanisms before breeders can develop a more resistant variety. She outlines the progress ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies